Table 3. Comparison of admission and... | American Society of Hematology

Table 3.

Comparison of admission and outcome variables by primary drug treatment

Variable	Quinine	Artesunate or DHA	P
No.	7	13	—
Admission hematocrit, %^3-150	37.5 (31.0-44.0)	41.5 (37.8-45.3)	.2
Admission parasitemia/μL^3-152,^3-153	288 536 (119 647-695 825)	280 673 (158 307-497 508)	.9
Admission reticulocyte count/μL^3-150,^3-153	46 849 (8354-85 344)	56 559 (33 706-79 411)	.6
Admission RESA-RBC/μL^3-152,^3-153	16 338 (9629-27 714)	11 609 (7490-17 993)	.3
Admission parasitemia:RESA-RBC ratio^3-151	21:1 (3:1-140:1)	30:1 (1:1-179:1)	.8
Parasite clearance time, hr^3-151	84 (60-108)	60 (30-102)	.07
PRR_0-24 hr^3-151	10 (2-17)	16 (1-1335)	.18
Peak reticulocyte count/μL^3-150,^3-153	226 044 (142 341-309 748)	222 312 (144 033-300 591)	.9
Peak RESA-RBC count/μL^3-151,^3-152	55 157 (39 710-76 630)	73 097 (46 121-115 824)	.3
Time to peak RESA-RBC count, hr^3-151	48 (6-303)	45 (2-548)	.9
Mean RESA-RBC life, hr^3-152	282 (181-440)	145 (102-205)	.02
Mean red cell life, hr^3-150	1062 (700-1425)	1006 (752-1261)	.8
RESA-RBC MRT, hr^3-150	286 (236-337)	281 (204-357)	.9
No. with RESA antibodies detected	2	3	.6
RESA-RBC:red cell mean life ratio^3-151	0.29:1.0 (0.11:1.0-0.65:1.0)	0.16:1.0 (0.05:1.0-0.29:1.0)	.09
Fractional RESA-RBC increment, 24 hr^3-151	0.4 (−0.2-5.4)	1.9 (0.1-9.2)	.04
Fractional RESA-RBC increment, peak^3-151	2.1 (0.3-5.6)	5.0 (0.4-17.0)	.18

Variable	Quinine	Artesunate or DHA	P
No.	7	13	—
Admission hematocrit, %^3-150	37.5 (31.0-44.0)	41.5 (37.8-45.3)	.2
Admission parasitemia/μL^3-152,^3-153	288 536 (119 647-695 825)	280 673 (158 307-497 508)	.9
Admission reticulocyte count/μL^3-150,^3-153	46 849 (8354-85 344)	56 559 (33 706-79 411)	.6
Admission RESA-RBC/μL^3-152,^3-153	16 338 (9629-27 714)	11 609 (7490-17 993)	.3
Admission parasitemia:RESA-RBC ratio^3-151	21:1 (3:1-140:1)	30:1 (1:1-179:1)	.8
Parasite clearance time, hr^3-151	84 (60-108)	60 (30-102)	.07
PRR_0-24 hr^3-151	10 (2-17)	16 (1-1335)	.18
Peak reticulocyte count/μL^3-150,^3-153	226 044 (142 341-309 748)	222 312 (144 033-300 591)	.9
Peak RESA-RBC count/μL^3-151,^3-152	55 157 (39 710-76 630)	73 097 (46 121-115 824)	.3
Time to peak RESA-RBC count, hr^3-151	48 (6-303)	45 (2-548)	.9
Mean RESA-RBC life, hr^3-152	282 (181-440)	145 (102-205)	.02
Mean red cell life, hr^3-150	1062 (700-1425)	1006 (752-1261)	.8
RESA-RBC MRT, hr^3-150	286 (236-337)	281 (204-357)	.9
No. with RESA antibodies detected	2	3	.6
RESA-RBC:red cell mean life ratio^3-151	0.29:1.0 (0.11:1.0-0.65:1.0)	0.16:1.0 (0.05:1.0-0.29:1.0)	.09
Fractional RESA-RBC increment, 24 hr^3-151	0.4 (−0.2-5.4)	1.9 (0.1-9.2)	.04
Fractional RESA-RBC increment, peak^3-151	2.1 (0.3-5.6)	5.0 (0.4-17.0)	.18

Abbreviations are explained in Table 2.

Mean (95% CI).

Median (range).

Geometric mean (95% CI).

See Table 1.